Mofdrib 0.5% Eye Drop
Prescription Required
Product introduction
Mofdrib 0.5% Eye Drop is an antibiotic, used in the treatment of bacterial infections of the eye. It relieves the symptoms of the infection by stopping the further growth of the causative microorganisms.
Mofdrib 0.5% Eye Drop is used to treat variety of infections caused by multiple organisms which affect various parts of the body
Mofdrib 0.5% Eye Drop is used to treat variety of infections caused by multiple organisms which affect various parts of the body
Uses of Mofdrib Eye Drop
- Treatment of Bacterial eye infections
Benefits of Mofdrib Eye Drop
In Treatment of Bacterial eye infections
Mofdrib 0.5% Eye Drop is an antibiotic medicine. It works by stopping the growth of the bacteria that is causing the infection. It helps relieve symptoms such as pain, redness, itching or soreness caused due to eye infections. The dose and duration of treatment will be decided by your doctor based on your condition. Make sure you complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Side effects of Mofdrib Eye Drop
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Mofdrib
- Eye discomfort
- Dry eye
- Burning sensation in eye
How to use Mofdrib Eye Drop
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Hold the dropper close to the eye without touching it. Gently squeeze the dropper and place the medicine inside the lower eyelid. Wipe off the extra liquid.
How Mofdrib Eye Drop works
Mofdrib 0.5% Eye Drop is an antibiotic. It treats bacterial eye infections by preventing the bacteria from dividing and repairing. It does so stopping the action of a bacterial enzyme called DNA-gyrase.
Safety advice
Alcohol
No interaction found/established
Pregnancy
CONSULT YOUR DOCTOR
Mofdrib 0.5% Eye Drop may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Mofdrib 0.5% Eye Drop is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Mofdrib 0.5% Eye Drop may cause side effects which could affect your ability to drive.
Mofdrib 0.5% Eye Drop may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.
Mofdrib 0.5% Eye Drop may make you feel dizzy or light-headed, you may experience a sudden, transient loss of vision, or you may faint for a short period. This may affect your driving ability.
Kidney
No interaction found/established
Liver
No interaction found/established
What if you forget to take Mofdrib Eye Drop?
If you miss a dose of Mofdrib 0.5% Eye Drop, use it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Mofdrib 0.5% Eye Drop
βΉ96.0/Eye Drop
Moxicip Eye Drop
Cipla Ltd
βΉ190.33/eye drop
98% costlier
Moxigram Eye Drop
Micro Labs Ltd
βΉ154/eye drop
60% costlier
Mosi Eye Drop
FDC Ltd
βΉ84/eye drop
12% cheaper
Apdrops Eye Drop
Ajanta Pharma Ltd
βΉ169/eye drop
76% costlier
4 Quin Eye Drop
Entod Pharmaceuticals Ltd
βΉ130/eye drop
35% costlier
Quick tips
- You have been prescribed Mofdrib 0.5% Eye Drop for the treatment of bacterial infections of the eye.
- Do not skip any doses and finish the full course of treatment even if you feel better.
- Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the medication.
- Do not touch the tip to any surface, or to your eye, to avoid contamination.
- Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
- It may cause short-term blurring of vision when first used. Use caution before driving or using machines.
- Do not wear contact lenses until your infection clears up.
- Make sure to use it within 4 weeks of opening the medication.
- You have been prescribed Mofdrib 0.5% Eye Drop for the treatment of bacterial infections of the eye.
- Do not skip any doses and finish the full course of treatment even if you feel better.
- Apply pressure on the corner of the eye (close to the nose) for about 1 minute, immediately after instilling the medication.
- Do not touch the tip to any surface, or to your eye, to avoid contamination.
- Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
- It may cause short-term blurring of vision when first used. Use caution before driving or using machines.
- Do not wear contact lenses until your infection clears up.
- Make sure to use it within 4 weeks of opening the medication.
Fact Box
Chemical Class
Fluoroquinolone
Habit Forming
No
Therapeutic Class
OPHTHAL
Action Class
Quinolones/ Fluroquinolones
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 940-41.
- Moxifloxacin. Camberley Surrey: Novartis Pharmaceuticals; 2009 [revised 19 Sep. 2018]. [Accessed 01 Apr. 2019] (online) Available from:
- Moxifloxacin. Worth, Texas: Alcon Laboratories, Inc; 2003. [Accessed 01 Apr. 2019] (online) Available from:
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98. [Accessed 01 Apr. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 01 Apr. 2019] (online) Available from:
Marketer details
Name: Akrovis Pharmaceuticals
Address: Delhi, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
61 people viewed this recentlyMRP
βΉ96
Inclusive of all taxes
5.0 ml in 1 bottle
SOLD OUT